Mycoses
Издатель: Wiley · ISSN 09337407 · 7 статей
-
Azole Resistance in Aspergillus fumigatus Infections Remains Low in Germany and Is Mainly Related to Environmental Resistance Mutations
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
-
From Skin Commensals to Bloodstream Pathogens: In Vitro Virulence Traits and In Vivo Pathogenicity of Malassezia Isolates
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...
-
Azole‐Resistant Aspergillosis: An Emerging Diagnostic and Therapeutic Challenge in Paediatrics
ABSTRACT Introduction Invasive aspergillosis (IA) represents one of the most frequent invasive fungal infections in paediatric patients with risk factors. An increase in cases of azole‐resistant IA has been reported in adult patients....
-
Clinical Impact of Haemophagocytic Lymphohistiocytosis Among Patients With HIV/AIDS and Disseminated Histoplasmosis in a Hyperendemic Region of Northeastern Brazil
ABSTRACT Background Haemophagocytic lymphohistiocytosis (HLH) is a life‐threatening hyperinflammatory syndrome that may occur in people living with HIV/AIDS (PLWHA), often triggered by opportunistic infections such as disseminated...
-
Between Skin and Brain: A Systematic Review of 712 Cases 1976–2025 Reveals a Highly Diverse Disease Spectrum in Chaetothyriales
ABSTRACT Background Black yeast‐like species of the order Chaetothyriales cause superficial to life‐threatening systemic infections. Comprehensive global epidemiology data remain limited. Objectives This study aimed to analyze the...
-
Real‐World Use of Rezafungin for the Treatment of Challenging Aspergillus Infections
ABSTRACT Background Aspergillus infections can pose significant treatment challenges, due in part to increasing triazole resistance. Clinical insight is needed to understand the potential for rezafungin, a next‐generation echinocandin...
-
Issue Information
Mycoses, Volume 69, Issue 11, November 2026.